All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter
No algorithm. No AI slop. No ads. Just RSS. Pro-human. Indie writers. Real journalism. Open web. Chronological. Hand toasted.

First human treated in gene therapy trial aiming to reverse cellular aging through partial reprogramming

By

Heidi Ledford

7d ago· 6 min readenNews

Summary

A landmark clinical trial has begun treating the first human participant with a gene therapy that aims to reverse cellular aging. The approach involves activating three genes to "partially reprogram" aged cells, making them behave younger. The initial application targets glaucoma, a blindness-causing disease, with the broader hope that this technique could eventually rejuvenate old organs.

Source

bskyFirst human treated in gene therapy trial aiming to reverse cellular aging through partial reprogrammingscientificamerican.com

Key quotes

· 3 pulled
Test time has arrived: the first person has been treated in a highly anticipated gene therapy trial that aims to coax aged cells to take on a younger identity.
The clinical trial will test a novel approach that involves turning on three genes that seem to 'partially reprogram' old cells, allowing them to behave as if they were young again.
Some scientists argue that partial reprogramming could rejuvenate old organs.
Snippet from the RSS feed
The first participant has been treated in a landmark clinical trial of cellular reprogramming, which aims to rejuvenate aging cells

You might also wanna read